Dr. Fortin is a medicinal chemist who completed his Ph.D. in cotutelle from both Université Laval in Canada and the Université d’Auvergne 1 in France (2010). Afterward, he was a postdoctoral fellow at Université du Québec à Trois-Rivières (2013), he became an assistant professor in 2013 and a associate professor in 2018 at the Faculté de pharmacie, Université Laval. Dr. Fortin is a researcher at the Centre de recherche du CHU de Québec-Université Laval and the director of the pharmaceutical chemistry laboratory located at the Hôpital Saint-François d’Assise. He is the author and co-author of 39 publications and 84 presentations.
Title : Targeting breast cancer through prodrug activation by cytochrome P450 1A1